News & insights

BioSapien is building partnership pathways around clinical validation, platform expansion.

Dark teal background with a textured pattern of varying sizes of bubbles and droplets scattered unevenly across the surface.

Read our News

Awards
August 14, 2026
Eastern Progress

BioSapien Nominated as 2026 Prix Galien USA Awards “Best Startup”

BioSapien was nominated for "Best Startup" at the 2026 Prix Galien USA Awards as its localized cancer drug delivery platform, MediChip™, prepares for clinical trials.

Read More
Read More
Media Coverage
June 26, 2026
the national news

Abu Dhabi to Trial New Cancer Treatment in Drive to 'Revolutionise' Chemotherapy

Abu Dhabi is launching clinical trials for BioSapien's MediChip, a 3D-printed mesh delivering targeted chemotherapy to colorectal cancer tumors to boost effectiveness and reduce side effects.

Read More
Read More
Media Coverage
June 24, 2026
FWD Start

BioSapien Wins Abu Dhabi Regulatory Approvals to Begin Phase I Cancer Trials for MediChip Platform

BioSapien secured full regulatory approvals from Abu Dhabi health authorities to begin Phase I clinical trials for its MediChip™ localized cancer treatment platform in colorectal cancer patients.

Read More
Read More
Awards
June 9, 2026
BUSINESS WIRE

BioSapien Wins 2026 Startup World Cup Silicon Valley Regional Competition

BioSapien won the 2026 Startup World Cup Silicon Valley Regional Competition for its MediChip™ platform, advancing to the Grand Finale to compete for $1M in investment.

Read More
Read More
Press Releases
June 1, 2026
PR NEWSWIRE

BioSapien Announces World-Class US Manufacturing Partners: Roswell Park & BA Sciences

BioSapien partnered with Roswell Park and BA Sciences to manufacture and test its 3D-printed MediChip™ drug delivery platform, clearing production ahead of Phase I colorectal cancer trials in the UAE.

Read More
Read More
Media Coverage
July 7, 2025
WAYA

UAE’s BioSapien Extends Pre-Series A to Over USD 8M Backed by Globivest

BioSapien raised over $8 million in extended pre-Series A funding backed by Globivest to advance MediChip™, its 3D-printed localized cancer treatment platform.

Read More
Read More
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Help shape the future of localized
cancer therapy.

Whether you're a pharmaceutical company, research institution, clinical investigator, or strategic partner, we're building the next generation of localized oncology treatments together.

 Get In Touch
Partner With Us
Trusted Client Logo

Developing localized drug delivery platforms for oncology. Treating cancer precisely where it lives.

Site Navigation
HomePartnershipsNewsContact Us
Contact Us
media@biosapien.com
+1 (917) 647-8600
11772 Sorrento Valley Road
San Diego, CA 92121
USA
ADGM Building, Abu Dhabi Global Market Square
Al Maryah Island, Abu Dhabi
UAE
LinkedIn
Privacy Policy
Terms & Conditions
© 2026 BioSapien, Inc. All rights reserved.
A hand gently touching green moss growing on a tree trunk in a natural outdoor setting.